Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Bacterial vaccines for splenectomized patients.

K T Kafidi1, J C Rotschafer

  • 1College of Pharmacy, University of Minnesota, St. Paul.

Drug Intelligence & Clinical Pharmacy
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Plasmid-mediated complementation of gyrA and gyrB in fluoroquinolone-resistant Bacteroides fragilis.

The Journal of antimicrobial chemotherapy·2003
Same author

In vitro pharmacodynamic analysis of single daily dosing versus conventional dosing of gentamicin administered with penicillin against Enterococcus faecalis.

Pharmacotherapy·2002
Same author

Pharmacodynamics of trovafloxacin and levofloxacin against Bacteroides fragilis in an in vitro pharmacodynamic model.

Antimicrobial agents and chemotherapy·2001
Same author

What do we really know about antibiotic pharmacodynamics?

Pharmacotherapy·2001
Same author

Comparison of once-daily versus twice-daily administration of cefdinir against typical bacterial respiratory tract pathogens.

Antimicrobial agents and chemotherapy·2001
Same author

Fluoroquinolone resistance in anaerobic bacteria following exposure to levofloxacin, trovafloxacin, and sparfloxacin in an in vitro pharmacodynamic model.

Antimicrobial agents and chemotherapy·2001

Individuals without a spleen face a higher risk of severe bacterial infections. Vaccination is recommended to reduce this risk, despite current vaccine limitations and potential side effects.

Area of Science:

  • Immunology
  • Infectious Diseases
  • Microbiology

Background:

  • The spleen plays a crucial role in immune defense against encapsulated bacteria.
  • Asplenic individuals are highly susceptible to severe infections from Streptococcus pneumoniae, Hemophilus influenzae, and Neisseria meningitidis.

Purpose of the Study:

  • To review the role of the spleen in immunity.
  • To discuss the risks of infection in asplenic individuals.
  • To evaluate the current recommendations for vaccination in asplenic populations.

Main Methods:

  • Literature review of spleen function and infection risk in asplenic individuals.
  • Analysis of available vaccines against encapsulated bacteria.
  • Assessment of current vaccination guidelines and future research directions.

Related Experiment Videos

Main Results:

  • Asplenic individuals have a significantly increased risk of fulminant infections.
  • Polysaccharide vaccines are available but require further data for optimal use in specific groups.
  • Ongoing research aims to develop more immunogenic vaccines.

Conclusions:

  • Despite limitations, current vaccines should be administered to asplenic individuals to mitigate life-threatening infection risks.
  • Further research is needed to define optimal vaccination strategies and develop improved vaccines for broader efficacy.